Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Nvidia unveils $100bn investment on OpenAI

(Sharecast News) - US chipmaking giant Nvidia said it was investing up to $100bn in ChatGPT creator OpenAI and provide it with data center chips, the two companies said late on Monday. A letter of intent signed by the companies stated the first gigawatt of Nvidia systems will be deployed in the second half of 2026. Nvidia will deploy at least 10 gigawatts of chips for OpenAI's artificial intelligence infrastructure.

The announcement comes after Nvidia agreed to pump $5bn into chipmaker Intel and a unveiled a £2bn investment in the UK's AI sector.

"Compute infrastructure will be the basis for the economy of the future, and we will utilize what we're building with Nvidia to both create new AI breakthroughs and empower people and businesses with them at scale," said OpenAI chief executive Sam Altman in a statement.

"Building this infrastructure is critical to everything we want to do," Altman later told CNBC. "Without doing this, we cannot deliver the services people want. We can't keep making better models."

The AI market has become the subject of fierce competition with China's DeepSeek spending just $294,000 training its R1 model.

Nvidia has come under pressure from both the Chinese and the US governments. Beijing last week accused it of violating its anti-monopoly laws and also reportedly ordered its top technology companies to halt purchases of the firm's AI chips.

Meanwhile, Nvidia and rival AMD agreed to pay the US government 15% of Chinese revenues to secure export licences to China to avoid a ban on AI chip sales to the country.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.